Artificial Intelligence And The Future Of Medicine

| December 12, 2018

article image
Washington University researchers are working to develop artificial intelligence (AI) systems for health care, which have the potential to transform the diagnosis and treatment of diseases, helping to ensure that patients get the right treatment at the right time. In a new Viewpoint article published Dec. 10 in the Journal of the American Medical Association (JAMA), two AI experts at Washington University School of Medicine in St. Louis — Philip Payne, PhD, the Robert J. Terry Professor and director of the Institute for Informatics; and Thomas M. Maddox, MD, a professor of medicine and director of the Health Systems Innovation Lab — discuss the best uses for AI in health care and outline some of the challenges for implementing the technology in hospitals and clinics.

Spotlight

BG Medical

BG Medical is a unique Sales and Marketing Distribution Partner for next-generation Medical Devices and Disposables. Our proven success is to provide our partners with the market share and traction necessary to maximize short and long-term profits. We accomplish this with our highly trained and experienced Sales and Marketing Team.

OTHER ARTICLES

How Can Medical Cannabis Help to Manage Pain Conditions? – The Cannabis Exchange

Article | February 11, 2020

Pain management is one of the most common reasons for the use of medical cannabis products. However, despite many jurisdictions – including Canada, Germany, and the Netherlands – now allowing the prescription of medical cannabis for this purpose, there remains little ‘high-quality’ evidence to support, or oppose its efficacy. Madden et al. (2018) set out to review the evidence available in order to determine the efficacy of medical cannabis when employed in the management of various forms of musculoskeletal pain. The researchers analysed various studies that assessed the use of cannabinoids in the treatment of arthritis pain; back pain; postoperative pain; and trauma-related pain. It is estimated that up to 30% of the population may suffer from a non-cancer-related pain condition. As such a high percentage of people suffer from these conditions, the development of simple and safe therapies is an essential area of research. This is particularly important as the therapeutic options for people with chronic pain are increasingly limited.

Read More

WANT LESS “LIABILITY” AND MORE “RELIABILITY” FROM YOUR CLINICAL MOBILITY SOLUTION?

Article | February 11, 2020

I recently discussed the different ways that consumer-grade smartphones can compromise patients’ health, safety and overall care. However, some clinicians and healthcare administrators have indicated in recent months that they need help selecting the right enterprise-grade mobility solutions for their unique operating models and workflows. There are many different hardware and software options, and a single rugged device can come in multiple configurations. So, how do you know if you’re picking the right communication tools for your clinicians? The key is to first set performance expectations for the total mobility solution rather than the device alone.

Read More

How Pharma Companies Can Scale Up Their Knowledge Discovery with Semantic Similarity Search

Article | February 11, 2020

Pharma has deep roots in human history with centuries of folk pharmaceutical knowledge offering a hit-and-miss range of natural remedies. But the industry as we know it today actually emerged in the second half of the 19th century when the world’s first factory for the sole production of medicines was found. By the late 19th and early 20th century, some chemical companies had already begun using research labs to explore the medical applications for their products. Fast forward to today and the pharmaceutical sector is a global trillion-dollar industry. However, to ensure the safety and efficacy of drugs, the process of drug discovery and development is under extensive scrutiny and control on both national and global levels.

Read More

Do Clinical Trial Delays Mean Trouble for Pharmaceutical Stocks?

Article | February 11, 2020

Pharmaceutical stocks have been somewhat of a safe haven for investors as the coronavirus outbreak spread from China to the rest of the world. But as the pandemic deepened, now resulting in more than 782,000 cases worldwide, even these "safer" companies are beginning to feel the effects. The U.S. is now the coronavirus epicenter, with the most cases -- more than 161,000 as of today. Initial concerns for drugmakers had to do with the supply of active pharmaceutical ingredients, which often come from China. The worry was that pharmaceutical companies wouldn't be able to produce enough of their drugs for patients.

Read More

Spotlight

BG Medical

BG Medical is a unique Sales and Marketing Distribution Partner for next-generation Medical Devices and Disposables. Our proven success is to provide our partners with the market share and traction necessary to maximize short and long-term profits. We accomplish this with our highly trained and experienced Sales and Marketing Team.

Events